Infectious Diseases – News and Features

Researchers have found that adding small quantities of liquid soap to some classes of pesticides can boost their potency. The discovery is promising news as malaria-carrying mosquitoes display an increasing resistance to current insecticides

A new MIT study finds that microglia with mutant TREM2 protein reduce brain circuit connections, promote inflammation and contribute to Alzheimer’s pathology in other ways.

Researchers have developed an effective and flexible antimicrobial material that could be used to coat medical devices placed inside the body, helping to prevent infection without drugs.

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant.

A new MIT study proposes a theoretical model that helps explain how cellular memory is passed from generation to generation when cells divide.

Researchers have discovered previously unknown changes in a specific type of liver cells, potentially opening avenues for a new treatment for liver fibrosis, a potentially life-threatening condition.

Traditional bone marrow aspirate (BMA) stem cell extraction methods are complex, time-consuming, and yield poor results due to antiquated centrifugation techniques.

Cannabinoids may have evolved to deter pests from chewing on them, according to experiments that showed higher cannabinoid concentrations in hemp leaves led to proportionately less damage from insect larvae.

Macrophages, a type of white blood cell that can destroy invading pathogens, have an innate ability to infiltrate tumor cells, making them a potentially important tool in treatments that use transplanted cells to fight disease, known as cell therapy.

Antimicrobial resistance (AMR) is threatening the effective treatment and prevention of a wide range of infections, with serious potential consequences for health and the economy. We spoke to Dr. Alaa Riezk, research associate at the Centre for Antimicrobial Optimisation (CAMO), Imperial College London, about the problem of usage and dosage of antimicrobials and AMR and how he and the team are working to address it.